Trametinib dimethyl sulfoxide
| Trametinib dimethyl sulfoxide | |
|---|---|
| Term | Trametinib dimethyl sulfoxide |
| Short definition | trametinib dimethyl sulfoxide - (pronounced) (truh-MEH-tih-nib dy-MEH-thul sul-FOK page) drug used alone or with dabrafenib to treat certain types of anaplastic thyroid cancer, non-small cell lung cancer, melanoma, and other solid tumors that have a specific mutation (change) in the BRAF gene. It is also being studied in the treatment of other types of cancer. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
trametinib dimethyl sulfoxide - (pronounced) (truh-MEH-tih-nib dy-MEH-thul sul-FOK page) drug used alone or with dabrafenib to treat certain types of anaplastic thyroid cancer, non-small cell lung cancer, melanoma, and other solid tumors that have a specific mutation (change) in the BRAF gene. It is also being studied in the treatment of other types of cancer. Trametinib dimethyl sulfoxide blocks proteins called MEK1 and MEK2, which can help prevent cancer cells from growing. It's a kind of kinase inhibitor. Also called a mekinist
External links
- Medical encyclopedia article on Trametinib dimethyl sulfoxide
- Wikipedia's article - Trametinib dimethyl sulfoxide
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski